HUMAN PAPILLOMA VIRUS
Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could two HPV shots be enough for women with HIV?
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether women living with HIV can get the same protection from the HPV vaccine with 2 doses instead of the usual 3. Researchers will compare immune responses in 275 Canadian women aged 18-45 who have never received the HPV vaccine. If 2 doses work as well, it …
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:52 UTC
-
New program aims to boost HPV vaccination in underserved populations
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether educational materials and a short video can help people who are underserved learn about the HPV vaccine and get it. The program is for Denver Health patients aged 9-26 who haven't started or finished the vaccine series. Researchers will measure changes in…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:43 UTC
-
Could a common numbing drug boost cancer surgery results?
Disease control Recruiting nowThis early-phase study tests whether injecting the numbing drug lidocaine directly into HPV-related throat tumors before robotic surgery is safe and can help kill more cancer cells. About 30 adults with oropharyngeal cancer will receive either lidocaine or no injection before the…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE1 • Sponsor: Ryan Carey • Aim: Disease control
Last updated May 26, 2026 06:56 UTC
-
New drug combo targets HPV-Caused throat tumors in early trial
Disease control Recruiting nowThis early-phase study tests two drugs, lenvatinib and pembrolizumab, in 20 people with HPV-related recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous growths in the airway. The goal is to see if the combination shrinks lung growths and reduces the need…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control Recruiting nowThis study is for people with HPV-positive throat cancer. It tests whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy works as well as the usual high dose (70 Gy) to control the cancer, while causing fewer side effects. About 121 participants will …
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Could a simple swab at home replace the pap smear for some women?
Diagnosis Recruiting nowThis study explores whether women can accurately collect their own samples to test for HPV, the virus that can cause cervical cancer. Researchers will compare results from two different self-collection kits to standard Pap smears. The goal is to make screening easier and more acc…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated May 26, 2026 04:38 UTC
-
Game-Changing cervical cancer prevention: Same-Day test and treat in one visit
Prevention Recruiting nowThis study aims to prevent cervical cancer by testing women for high-risk HPV and offering same-day treatment if needed. About 5,000 women in Honduras will use a self-sampling kit or have a provider-collected sample. The test gives results in under an hour, and AI imaging helps d…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Atila Biosystems Inc. • Aim: Prevention
Last updated May 26, 2026 06:47 UTC
-
New study aims to close cervical cancer gap for Scotland's most vulnerable women
Knowledge-focused Recruiting nowThis study looks at how to better prevent cervical cancer in women who have experienced homelessness, substance use, transactional sex, or incarceration. Researchers will offer HPV vaccination and testing during regular sexual health clinic visits to see if this approach works an…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Stanford launches massive study to unravel oropharyngeal cancer mysteries
Knowledge-focused Recruiting nowThis study aims to learn more about oropharyngeal carcinoma, a type of throat cancer, and its link to HPV. Researchers will collect blood samples from 1000 patients before treatment and at six follow-up visits, plus tumor tissue when available. The goal is to better understand ho…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC